Yasar Caliskan
Overview
Explore the profile of Yasar Caliskan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
128
Citations
1213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caliskan Y, Mikhalkova D, Afsar B, Afsar R, Al Rub F, Lentine K
Am J Transplant
. 2025 Mar;
PMID: 40057195
Evaluating kidney transplant candidates with transthyretin (TTR) variants requires a multidisciplinary approach, considering clinical, genetic, and psychosocial factors. Hereditary Transthyretin Amyloidosis (ATTR), an autosomal dominant disorder, can affect cardiovascular and...
2.
Afsar B, Afsar R, Caliskan Y, Lentine K
Int Urol Nephrol
. 2025 Mar;
PMID: 40038200
Renal risk variants in the apolipoprotein L1 (APOL1) gene confer protection against trypanosomiasis, but these risk variants (G1 and G2 variants) also predispose to kidney disease among individuals, especially from...
3.
Al Rub F, Afsar R, Fleetwood V, Bastani B, Randall H, Nazzal M, et al.
Transplantation
. 2025 Jan;
PMID: 39819994
Background: Recent studies suggest that approximately 10% of patients with chronic kidney disease (CKD) have disease-causing genetic variants, an observation relevant to evaluation of kidney transplant candidates. Methods: We retrospectively...
4.
Lin C, Keating C, Roth R, Caliskan Y, Nazzal M, Exil V, et al.
J Cardiovasc Dev Dis
. 2024 Nov;
11(11).
PMID: 39590192
Thoracic and abdominal aortic aneurysms (TAAs and AAAs, respectively) share morphological features but have distinct clinical and hereditary characteristics. Studies using bulk RNA comparisons revealed distinct patterns of gene expression...
5.
6.
Afsar B, Afsar R, Caliskan Y, Lentine K
Am J Cardiovasc Drugs
. 2024 Oct;
25(2):135-146.
PMID: 39476316
Thromboembolic events and atrial fibrillation are common among kidney transplant recipients (KTRs), and these conditions typically require anticoagulation. Traditionally, vitamin K antagonists were used for management, but the use of...
7.
Afsar B, Afsar R, Caliskan Y, Lentine K
Int Urol Nephrol
. 2024 Oct;
57(3):839-854.
PMID: 39470940
Although, kidney transplantation (KT) is the best treatment option for patients with end-stage kidney disease, long-term complications including chronic kidney allograft disease (CKAD) and major adverse cardiovascular events (MACE) are...
8.
Liu L, Zhu L, Monteiro-Martins S, Griffin A, Vlahos L, Fujita M, et al.
medRxiv
. 2024 Oct;
PMID: 39417133
IgA vasculitis (IgAV) is a pediatric disease with skin and systemic manifestations. Here, we conducted genome, transcriptome, and proteome-wide association studies in 2,170 IgAV cases and 5,928 controls, generated IgAV-specific...
9.
Afsar B, Afsar R, Caliskan Y, Lentine K
Transplant Rev (Orlando)
. 2024 Aug;
38(4):100876.
PMID: 39168019
Although kidney transplantation (KT) is the best treatment option for end-stage kidney disease, long-term complications such as chronic kidney allograft dysfunction and cardiovascular disorders are observed. To decrease these complications,...
10.
Manithody C, Denton C, Mehta S, Carter J, Kurashima K, Bagwe A, et al.
Am J Physiol Gastrointest Liver Physiol
. 2024 Aug;
327(5):G640-G654.
PMID: 39163019
Total parenteral nutrition (TPN) provides lifesaving nutritional support intravenously; however, it is associated with significant side effects. Given gut microbial alterations noted with TPN, we hypothesized that transferring fecal microbiota...